Impaired outcome of continuous ambulatory peritoneal dialysis in immunosuppressed patients

Nephrology Dialysis Transplantation

Volumn 11, Issue 6, 1996, Pages 1104-1108

  Andrews, P A ^a,b   Warr, K J ^a   Hicks, J A ^a   Cameron, J S ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

CAPD; Dialysis; Immunosuppression; Peritonitis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; BACTERIAL INFECTION; CATHETER INFECTION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DISEASE PREDISPOSITION; FEMALE; GLOMERULONEPHRITIS; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYCOSIS; PERITONITIS; PRIORITY JOURNAL; RISK FACTOR; STAPHYLOCOCCUS AUREUS; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

EID: 0030000884     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027463     Document Type: Article

References (16)

1. Churchill DN, Taylor DW, Vas SI et al. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multi-centre randomized clinical trial comparing the Y connector disinfectant system to standard systems. Perit Dial Int 1989; 9: 159-163
2. Vas SI. Infections of continuous ambulatory dialysis catheters. Int Dis Clin North Am 1989; 3: 301-328
3. Gokal R. Peritoneal dialysis. In: Cameron JS, Davison AM, Grünfeld J-P, Kerr D, Ritz B, eds. Oxford Textbook of Nephrology. Oxford University Press, Oxford, 1992; 1477-1505
4. Michel C, Courdavalt L, al Khayat R, Viron B, Roux P, Mignon F. Fungal peritonitis in patients on peritoneal dialysis. Am J Nephrol 1994; 14: 113-120
5. Allais JM, Cavalieri SJ, Bierman MH, Clark RB. Listeria monocytogenes in a patient on continuous ambulatory peritoneal dialysis. Neb Med J 1989; 74: 303-305
6. Khan IH, Catto GR. Long-term complications of dialysis: infection. Kidney Int 1993; S41: S143-148
7. Lewis SL, van Epps DE. Neutrophil and monocyte alterations in chronic dialysis patients. Am J Kidney Dis 1987; 9: 381-395
8. Lamperi S, Carozzi S. Immunological defences in continuous ambulatory peritoneal dialysis. Blood Purif 1989; 7: 126-143
9. Dasgupta MK, Costerton JW. Significance of biofilm-adherent bacterial microcolonies on Tenckhoff catheters of CAPD patients: current concepts of CAPD. Blood Purif 1989; 7: 144-155
10. Dressier R, Peters AT, Lynn RI. Pseudomonal and candidal peritonitis as a complication of continuous ambulatory peritoneal dialysis in human immunodeficiency virus-infected patients. Am J Med 1989; 86: 787-790
11. Perazella M, Eisen T, Brown E. Peritonitis associated with disseminated Mycobacterium avium complex in an acquired immunodeficiency syndrome patient on chronic ambulatory peritoneal dialysis. Am J Kidney Dis 1993; 21: 319-321
12. Lewis M, Gorban-Brennan NL, Kliger A, Cooper K, Finkelstein FO. Incidence and spectrum of organisms causing peritonitis in HIV positive patients on CAPD. Adv Perit Dial 1990; 6: 136-138
13. Williams JD, Coles GA. Gram positive infections related to continuous ambulatory peritoneal dialysis. J Antimicrob Chemother 1991; 27 [Supp B]: 31-35
14. Taube D, Brown Z, Williams DG. Long-term impairment of suppressor-cell function by cyclophosphamide in minimal-change nephropathy and its association with therapeutic response. Lancet 1981; 1: 235-238
15. Müller TF, Heymanns J, Grebe SO, Lange H. Persistent long-term changes in lymphocyte subsets of renal allograft patients induced by polyclonal antibodies. XIIIth International Congress of Nephrology. Madrid, July 1995, Abstract Book p 342
16. Bargman JM. Nasal carriage of Staphylococcus aureus in dialysis patients. Semin Dial 1995; 8: 220-225